PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Korean Journal of Ophthalmology10.3341/kjo.2013.27.4.2992013274299Regression of Iris Neovascularization after Subconjunctival Injection of BevacizumabNa Kyung Ryoo, Eun Ji Lee, Tae-Woo Kimhttps://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2013.27.4.299, https://synapse.koreamed.org/pdf/10.3341/kjo.2013.27.4.299, http://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2013.27.4.299
Ophthalmic Research10.1159/000341734201349120-24Intrasilicone Bevacizumab Injection for Iris Neovascularization after Vitrectomy for Proliferative Diabetic RetinopathyAbdelrahman G. Salmanhttps://www.karger.com/Article/Pdf/341734, http://www.karger.com/Article/Pdf/341734
International Medical Case Reports Journal10.2147/imcrj.s1959902019Volume 1289-92

Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab

Nandita Anand, James J Reidy, Kamran M Riazhttps://www.dovepress.com/getfile.php?fileID=49093, https://www.dovepress.com/getfile.php?fileID=49093
Reactions Weekly10.1007/s40278-012-0030-420121431111-11Bevacizumabhttp://link.springer.com/content/pdf/10.1007/s40278-012-0030-4.pdf, http://link.springer.com/article/10.1007/s40278-012-0030-4/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-012-0030-4
International Ophthalmology10.1007/s10792-013-9732-82013335507-513The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularizationBanu Torun Acar, Elvin Halili, Suphi Acarhttp://link.springer.com/content/pdf/10.1007/s10792-013-9732-8.pdf, http://link.springer.com/article/10.1007/s10792-013-9732-8/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10792-013-9732-8
Journal of the Korean Ophthalmological Society10.3341/jkos.2017.58.8.9812017588981Two Cases of Corneal Neovascularization Improved by Electrocauterization and Subconjunctival Bevacizumab InjectionJun Soo Eun, Kyong Jin Chohttps://synapse.koreamed.org/pdf/10.3341/jkos.2017.58.8.981, https://synapse.koreamed.org/DOIx.php?id=10.3341/jkos.2017.58.8.981, https://synapse.koreamed.org/DOIx.php?id=10.3341/jkos.2017.58.8.981
Acta Ophthalmologica10.1111/j.1755-3768.2008.01399.x2009876653-658Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularizationIn-Cheon You, In-Seong Kang, Seung-Hyun Lee, Kyung-Chul Yoonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.2008.01399.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2008.01399.x/fullpdf
Acta Ophthalmologica10.1111/j.1755-3768.2009.2224.x2009870-0Subconjunctival injection of bevacizumab (Avastin®) for corneal neovascularizationMF DE LA PAZ, F DE SOUSA, C PONCE, J ALVAREZ, RI BARRAQUERhttp://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.2009.2224.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2009.2224.x/fullpdf
American Journal of Ophthalmology10.1016/j.ajo.2006.02.01520061421155-157.e1Regression of Iris Neovascularization After Intravitreal Injection of Bevacizumab in Patients With Proliferative Diabetic RetinopathyYusuke Oshima, Hirokazu Sakaguchi, Fumi Gomi, Yasuo Tanohttps://api.elsevier.com/content/article/PII:S0002939406002558?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0002939406002558?httpAccept=text/plain
Case Reports in Ophthalmology10.1159/0005101142020113652-657Resolution of Refractory Corneal Neovascularization with Subconjunctival BevacizumabAnna Krystyna Britton, Basil Bamford Crayfordhttps://www.karger.com/Article/Pdf/510114, https://www.karger.com/Article/Pdf/510114